Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - PRE-TAX INCOME
Pre-tax Income TRVI - Trevi Therapeutics, Inc.
-29.1 M
LAST VALUE
7.44%
2 YEAR CAGR
-7.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR